Skip to main content
Erschienen in: Cardiovascular Toxicology 2/2022

24.11.2021

Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

verfasst von: Yiqi Gong, Li Yang, Jun Tang, Jijian Zheng, Nevin Witman, Philipp Jakob, Yao Tan, Minglu Liu, Ying Chen, Huijing Wang, Wei Fu, Wei Wang

Erschienen in: Cardiovascular Toxicology | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Yohimbine is a highly selective and potent α2-adrenoceptor antagonist, which is usually treated as an adjunction for impotence, as well for weight loss and natural bodybuilding aids. However, it was recently reported that Yohimbine causes myocardial injury and controversial results were reported in the setting of cardiac diseases. Here, we used human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) as a model system to explore electrophysiologic characterization after exposure to Yohimbine. HiPSC-CMs were differentiated by employment of inhibitory Wnt compounds. For analysis of electrophysiological properties, conventional whole-cell patch-clamp recording was used. Specifically, spontaneous action potentials, pacemaker currents (If), sodium (Na+) channel (INa), and calcium (Ca++) channel currents (ICa) were assessed in hiPSC-CMs after exposure to Yohimbine. HiPSC-CMs expressed sarcomeric-α-actinin and MLC2V proteins, as well as exhibited ventricular-like spontaneous action potential waveform. Yohimbine inhibited frequency of hiPSC-CMs spontaneous action potentials and significantly prolonged action potential duration in a dose-dependent manner. In addition, rest potential, threshold potential, amplitude, and maximal diastolic potential were decreased, whereas APD50/APD90 was prolonged. Yohimbine inhibited the amplitude of INa in low doses (IC50 = 14.2 μM, n = 5) and inhibited ICa in high doses (IC50 = 139.7 μM, n = 5). Whereas Yohimbine did not affect the activation curves, treatment resulted in left shifts in inactivation curves of both Na+ and Ca++ channels. Here, we show that Yohimbine induces direct cardiotoxic effects on spontaneous action potentials of INa and ICa in hiPSC-CMs. Importantly, these effects were not mediated by α2-adrenoceptor signaling. Our results strongly suggest that Yohimbine directly and negatively affects electrophysiological properties of human cardiomyocytes. These findings are highly relevant for potential application of Yohimbine in patients with atrioventricular conduction disorder.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Anversa, P., Kajstura, J., Rota, M., et al. (2013). Regenerating new heart with stem cells. The Journal of Clinical Investigation, 123, 62–70. PubMedPubMedCentral Anversa, P., Kajstura, J., Rota, M., et al. (2013). Regenerating new heart with stem cells. The Journal of Clinical Investigation, 123, 62–70. PubMedPubMedCentral
2.
Zurück zum Zitat Joggerst, S. J., & Hatzopoulos, A. K. (2009). Stem cell therapy for cardiac repair: benefits and barriers. Expert Reviews in Molecular Medicine, 11, e20. PubMed Joggerst, S. J., & Hatzopoulos, A. K. (2009). Stem cell therapy for cardiac repair: benefits and barriers. Expert Reviews in Molecular Medicine, 11, e20. PubMed
3.
Zurück zum Zitat Magdy, T., Schuldt, A. J. T., Wu, J. C., et al. (2018). Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: Opportunities and problems. Annual Review of Pharmacology and Toxicology, 58, 83–103. PubMed Magdy, T., Schuldt, A. J. T., Wu, J. C., et al. (2018). Human induced pluripotent stem cell (hiPSC)-derived cells to assess drug cardiotoxicity: Opportunities and problems. Annual Review of Pharmacology and Toxicology, 58, 83–103. PubMed
4.
Zurück zum Zitat Burridge, P. W., Li, Y. F., Matsa, E., et al. (2016). Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nature Medicine, 22, 547–556. PubMedPubMedCentral Burridge, P. W., Li, Y. F., Matsa, E., et al. (2016). Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nature Medicine, 22, 547–556. PubMedPubMedCentral
6.
Zurück zum Zitat Sharma, A., McKeithan, W. L., Serrano, R., et al. (2018). Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nature Protocols, 13, 3018–3041. PubMedPubMedCentral Sharma, A., McKeithan, W. L., Serrano, R., et al. (2018). Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity. Nature Protocols, 13, 3018–3041. PubMedPubMedCentral
7.
Zurück zum Zitat McKeithan, W. L., Feyen, D. A. M., Bruyneel, A. A. N., et al. (2020). Reengineering an antiarrhythmic drug using patient hiPSC cardiomyocytes to improve therapeutic potential and reduce toxicity. Cell Stem Cell, 27, 813–21.e6. PubMedPubMedCentral McKeithan, W. L., Feyen, D. A. M., Bruyneel, A. A. N., et al. (2020). Reengineering an antiarrhythmic drug using patient hiPSC cardiomyocytes to improve therapeutic potential and reduce toxicity. Cell Stem Cell, 27, 813–21.e6. PubMedPubMedCentral
8.
Zurück zum Zitat Yang, L., Gong, Y., Tan, Y., et al. (2021). Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism. Ann Transl Med, 9, 399. PubMedPubMedCentral Yang, L., Gong, Y., Tan, Y., et al. (2021). Dexmedetomidine exhibits antiarrhythmic effects on human-induced pluripotent stem cell-derived cardiomyocytes through a Na/Ca channel-mediated mechanism. Ann Transl Med, 9, 399. PubMedPubMedCentral
9.
Zurück zum Zitat Stoelzle, S., Haythornthwaite, A., Kettenhofen, R., et al. (2011). Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction. Journal of Biomolecular Screening, 16, 910–916. PubMed Stoelzle, S., Haythornthwaite, A., Kettenhofen, R., et al. (2011). Automated patch clamp on mESC-derived cardiomyocytes for cardiotoxicity prediction. Journal of Biomolecular Screening, 16, 910–916. PubMed
10.
Zurück zum Zitat Scheel, O., Frech, S., Amuzescu, B., et al. (2014). Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology. ASSAY and Drug Development Technologies, 12, 457–469. PubMed Scheel, O., Frech, S., Amuzescu, B., et al. (2014). Action potential characterization of human induced pluripotent stem cell-derived cardiomyocytes using automated patch-clamp technology. ASSAY and Drug Development Technologies, 12, 457–469. PubMed
11.
Zurück zum Zitat Richardson, E. S., & Xiao, Y.-F., et al. (2010). Electrophysiology of single cardiomyocytes: Patch clamp and other recording Methods. In D. C. Sigg, P. A. Iaizzo, & Y.-F. Xiao (Eds.), Cardiac Electrophysiology methods and models (pp. 329–348). Springer, US. Richardson, E. S., & Xiao, Y.-F., et al. (2010). Electrophysiology of single cardiomyocytes: Patch clamp and other recording Methods. In D. C. Sigg, P. A. Iaizzo, & Y.-F. Xiao (Eds.), Cardiac Electrophysiology methods and models (pp. 329–348). Springer, US.
12.
Zurück zum Zitat Liu, J., Laksman, Z., & Backx, P. H. (2016). The electrophysiological development of cardiomyocytes. Advanced Drug Delivery Reviews, 96, 253–273. PubMed Liu, J., Laksman, Z., & Backx, P. H. (2016). The electrophysiological development of cardiomyocytes. Advanced Drug Delivery Reviews, 96, 253–273. PubMed
13.
Zurück zum Zitat Goldberg, M. R., & Robertson, D. (1983). Yohimbine: A pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacological Reviews, 35, 143–180. PubMed Goldberg, M. R., & Robertson, D. (1983). Yohimbine: A pharmacological probe for study of the alpha 2-adrenoreceptor. Pharmacological Reviews, 35, 143–180. PubMed
14.
Zurück zum Zitat Ho, C. C. K., & Tan, H. M. (2011). Rise of herbal and traditional medicine in erectile dysfunction management. Current Urology Reports, 12, 470–478. PubMed Ho, C. C. K., & Tan, H. M. (2011). Rise of herbal and traditional medicine in erectile dysfunction management. Current Urology Reports, 12, 470–478. PubMed
15.
Zurück zum Zitat Tam, S. W., Worcel, M., & Wyllie, M. (2001). Yohimbine: A clinical review. Pharmacology & Therapeutics, 91, 215–243. Tam, S. W., Worcel, M., & Wyllie, M. (2001). Yohimbine: A clinical review. Pharmacology & Therapeutics, 91, 215–243.
16.
Zurück zum Zitat McCarty, M. F. (2002). Pre-exercise administration of Yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis. Medical Hypotheses, 58, 491–495. PubMed McCarty, M. F. (2002). Pre-exercise administration of Yohimbine may enhance the efficacy of exercise training as a fat loss strategy by boosting lipolysis. Medical Hypotheses, 58, 491–495. PubMed
17.
Zurück zum Zitat Ostojic, S. M. (2006). Yohimbine: The effects on body composition and exercise performance in soccer players. Research in Sports Medicine, 14, 289–299. PubMed Ostojic, S. M. (2006). Yohimbine: The effects on body composition and exercise performance in soccer players. Research in Sports Medicine, 14, 289–299. PubMed
18.
Zurück zum Zitat Peskind, E. R., Wingerson, D., Murray, S., et al. (1995). Effects of Alzheimer’s disease and normal aging on cerebrospinal fluid norepinephrine responses to Yohimbine and Clonidine. Archives of General Psychiatry, 52, 774–782. PubMed Peskind, E. R., Wingerson, D., Murray, S., et al. (1995). Effects of Alzheimer’s disease and normal aging on cerebrospinal fluid norepinephrine responses to Yohimbine and Clonidine. Archives of General Psychiatry, 52, 774–782. PubMed
19.
Zurück zum Zitat Petrie, E. C., Peskind, E. R., Dobie, D. J., et al. (2000). Increased plasma norepinephrine response to Yohimbine in elderly men. The Journals of Gerontology: Series A, 55, M155–M159. Petrie, E. C., Peskind, E. R., Dobie, D. J., et al. (2000). Increased plasma norepinephrine response to Yohimbine in elderly men. The Journals of Gerontology: Series A, 55, M155–M159.
20.
Zurück zum Zitat Friesen, K., Palatnick, W., & Tenenbein, M. (1993). Benign course after massive ingestion of yohimbine. The Journal of Emergency Medicine, 11, 287–288. PubMed Friesen, K., Palatnick, W., & Tenenbein, M. (1993). Benign course after massive ingestion of yohimbine. The Journal of Emergency Medicine, 11, 287–288. PubMed
21.
Zurück zum Zitat Linden, C. H., Vellman, W. P., & Rumack, B. (1985). Yohimbine: A new street drug. Annals of Emergency Medicine, 14, 1002–1004. PubMed Linden, C. H., Vellman, W. P., & Rumack, B. (1985). Yohimbine: A new street drug. Annals of Emergency Medicine, 14, 1002–1004. PubMed
22.
Zurück zum Zitat Song, J., & Sharman, T. (2019). Yohimbine induced type II myocardial injury: An underrecognized and dangerous adverse effect. American Journal of Medical Case Reports, 7, 271–273. Song, J., & Sharman, T. (2019). Yohimbine induced type II myocardial injury: An underrecognized and dangerous adverse effect. American Journal of Medical Case Reports, 7, 271–273.
23.
Zurück zum Zitat Giampreti, A., Lonati, D., Locatelli, C., et al. (2009). Acute neurotoxicity after yohimbine ingestion by a body builder. Clinical Toxicology, 47, 827–829. PubMed Giampreti, A., Lonati, D., Locatelli, C., et al. (2009). Acute neurotoxicity after yohimbine ingestion by a body builder. Clinical Toxicology, 47, 827–829. PubMed
24.
Zurück zum Zitat Drevin, G., Palayer, M., Compagnon, P., et al. (2020). A fatal case report of acute yohimbine intoxication. Forensic Toxicology, 38, 287–291. Drevin, G., Palayer, M., Compagnon, P., et al. (2020). A fatal case report of acute yohimbine intoxication. Forensic Toxicology, 38, 287–291.
25.
Zurück zum Zitat Gu, H., Huang, X., Xu, J., et al. (2018). Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood. Stem Cell Research & Therapy, 9, 163. Gu, H., Huang, X., Xu, J., et al. (2018). Optimizing the method for generation of integration-free induced pluripotent stem cells from human peripheral blood. Stem Cell Research & Therapy, 9, 163.
26.
Zurück zum Zitat Lian, X., Zhang, J., Azarin, S. M., et al. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nature Protocols, 8, 162–175. PubMed Lian, X., Zhang, J., Azarin, S. M., et al. (2013). Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nature Protocols, 8, 162–175. PubMed
27.
Zurück zum Zitat Burridge, P. W., Matsa, E., Shukla, P., et al. (2014). Chemically defined generation of human cardiomyocytes. Nature Methods, 11, 855–860. PubMedPubMedCentral Burridge, P. W., Matsa, E., Shukla, P., et al. (2014). Chemically defined generation of human cardiomyocytes. Nature Methods, 11, 855–860. PubMedPubMedCentral
28.
29.
Zurück zum Zitat Denning, C., Borgdorff, V., Crutchley, J., et al. (2016). Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1863, 1728–48. Denning, C., Borgdorff, V., Crutchley, J., et al. (2016). Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1863, 1728–48.
30.
Zurück zum Zitat Bedada, F. B., Wheelwright, M., & Metzger, J. M. (2016). Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1863, 1829–38. Bedada, F. B., Wheelwright, M., & Metzger, J. M. (2016). Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes. Biochimica et Biophysica Acta (BBA)—Molecular Cell Research, 1863, 1829–38.
31.
Zurück zum Zitat Gong, Y., Chen, Z., Yang, L., et al. (2020). Intrinsic color sensing system allows for real-time observable functional changes on human induced pluripotent stem cell-derived cardiomyocytes. ACS Nano, 14, 8232–8246. PubMed Gong, Y., Chen, Z., Yang, L., et al. (2020). Intrinsic color sensing system allows for real-time observable functional changes on human induced pluripotent stem cell-derived cardiomyocytes. ACS Nano, 14, 8232–8246. PubMed
32.
Zurück zum Zitat Zhao, Z., Lan, H., El-Battrawy, I., et al. (2018). Ion channel expression and characterization in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cells International, 2018, 6067096. PubMedPubMedCentral Zhao, Z., Lan, H., El-Battrawy, I., et al. (2018). Ion channel expression and characterization in human induced pluripotent stem cell-derived cardiomyocytes. Stem Cells International, 2018, 6067096. PubMedPubMedCentral
33.
Zurück zum Zitat Paci, M., Hyttinen, J., Rodriguez, B., et al. (2015). Human induced pluripotent stem cell-derived versus adult cardiomyocytes: An in silico electrophysiological study on effects of ionic current block. British Journal of Pharmacology, 172, 5147–5160. PubMedPubMedCentral Paci, M., Hyttinen, J., Rodriguez, B., et al. (2015). Human induced pluripotent stem cell-derived versus adult cardiomyocytes: An in silico electrophysiological study on effects of ionic current block. British Journal of Pharmacology, 172, 5147–5160. PubMedPubMedCentral
34.
Zurück zum Zitat Liang, P., Lan, F., Lee, A. S., et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation, 127, 1677–1691. PubMed Liang, P., Lan, F., Lee, A. S., et al. (2013). Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation, 127, 1677–1691. PubMed
35.
Zurück zum Zitat Colatsky, T., Fermini, B., Gintant, G., et al. (2016). The comprehensive in vitro Proarrhythmia Assay (CiPA) initiative—Update on progress. Journal of Pharmacological and Toxicological Methods, 81, 15–20. PubMed Colatsky, T., Fermini, B., Gintant, G., et al. (2016). The comprehensive in vitro Proarrhythmia Assay (CiPA) initiative—Update on progress. Journal of Pharmacological and Toxicological Methods, 81, 15–20. PubMed
36.
Zurück zum Zitat Xiao, R.-P., Zhu, W., Zheng, M., et al. (2006). Subtype-specific α1- and β-adrenoceptor signaling in the heart. Trends in Pharmacological Sciences, 27, 330–337. PubMed Xiao, R.-P., Zhu, W., Zheng, M., et al. (2006). Subtype-specific α1- and β-adrenoceptor signaling in the heart. Trends in Pharmacological Sciences, 27, 330–337. PubMed
37.
Zurück zum Zitat Northover, B. J. (1983). A comparison of the electrophysiological actions of phentolamine with those of some other antiarrhythmic drugs on tissues isolated from the rat heart. British Journal of Pharmacology, 80, 85–93. PubMedPubMedCentral Northover, B. J. (1983). A comparison of the electrophysiological actions of phentolamine with those of some other antiarrhythmic drugs on tissues isolated from the rat heart. British Journal of Pharmacology, 80, 85–93. PubMedPubMedCentral
38.
Zurück zum Zitat Azuma, J., Vogel, S., Josephson, I., et al. (1978). Yohimbine blockade of ionic channels in myocardial cells. European Journal of Pharmacology, 51, 109–119. PubMed Azuma, J., Vogel, S., Josephson, I., et al. (1978). Yohimbine blockade of ionic channels in myocardial cells. European Journal of Pharmacology, 51, 109–119. PubMed
39.
Zurück zum Zitat Hasegawa, J., Hirai, S., Saitoh, M., et al. (1988). Antiarrhythmic effects of alpha-adrenoceptor antagonists in guinea pig ventricular myocardium. Journal of the American College of Cardiology, 12, 1590–1598. PubMed Hasegawa, J., Hirai, S., Saitoh, M., et al. (1988). Antiarrhythmic effects of alpha-adrenoceptor antagonists in guinea pig ventricular myocardium. Journal of the American College of Cardiology, 12, 1590–1598. PubMed
40.
Zurück zum Zitat Satin, J., Kehat, I., Caspi, O., et al. (2004). Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. The Journal of Physiology, 559, 479–496. PubMedPubMedCentral Satin, J., Kehat, I., Caspi, O., et al. (2004). Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. The Journal of Physiology, 559, 479–496. PubMedPubMedCentral
41.
Zurück zum Zitat Poulet, C., Wettwer, E., Grunnet, M., et al. (2015). Late sodium current in human atrial cardiomyocytes from patients in sinus rhythm and atrial fibrillation. PLoS ONE, 10, e0131432. PubMedPubMedCentral Poulet, C., Wettwer, E., Grunnet, M., et al. (2015). Late sodium current in human atrial cardiomyocytes from patients in sinus rhythm and atrial fibrillation. PLoS ONE, 10, e0131432. PubMedPubMedCentral
42.
Zurück zum Zitat Morad, M., & Zhang, X.-H. (2017). Mechanisms of spontaneous pacing: sinoatrial nodal cells, neonatal cardiomyocytes, and human stem cell derived cardiomyocytes. Canadian Journal of Physiology and Pharmacology, 95, 1100–7. PubMed Morad, M., & Zhang, X.-H. (2017). Mechanisms of spontaneous pacing: sinoatrial nodal cells, neonatal cardiomyocytes, and human stem cell derived cardiomyocytes. Canadian Journal of Physiology and Pharmacology, 95, 1100–7. PubMed
Metadaten
Titel
Yohimbine Directly Induces Cardiotoxicity on Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
verfasst von
Yiqi Gong
Li Yang
Jun Tang
Jijian Zheng
Nevin Witman
Philipp Jakob
Yao Tan
Minglu Liu
Ying Chen
Huijing Wang
Wei Fu
Wei Wang
Publikationsdatum
24.11.2021
Verlag
Springer US
Erschienen in
Cardiovascular Toxicology / Ausgabe 2/2022
Print ISSN: 1530-7905
Elektronische ISSN: 1559-0259
DOI
https://doi.org/10.1007/s12012-021-09709-3

Weitere Artikel der Ausgabe 2/2022

Cardiovascular Toxicology 2/2022 Zur Ausgabe